يعرض 1 - 20 نتائج من 816 نتيجة بحث عن '"BİLİCİ, AHMET"', وقت الاستعلام: 0.77s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal

    وصف الملف: application/pdf

    Relation: Current Problems in Cancer; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Kutlu, Y., Çekin, R., Göktaş Aydın, S., Shbair, A. T. M., Bilici, A., Arıcı, S. . Şeker, M. (2024). Prognostic significance of HER2 loss after HER2-targeted neoadjuvant treatment in patients with HER2-positive locally advanced breast cancer. Current Problems in Cancer, 50. http://dx.doi.org/10.1016/j.currproblcancer.2024.101102; http://dx.doi.org/10.1016/j.currproblcancer.2024.101102; https://hdl.handle.net/20.500.12511/12567; 50; Q3; 001242968000001; 2-s2.0-85193027238; Q2

  7. 7
    Academic Journal

    مصطلحات موضوعية: CDX-2, Colon Cancer, Disease-Free Survival, Inflammatory Marker, MSI

    وصف الملف: application/pdf

    Relation: Journal of Gastrointestinal Cancer; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Aydın, S. G., Ölmez, Ö. F., Selvi, O., Geredeli, Ç., Özden, F., Bilici, A. . Aydın, A. (2024). The prognostic role of mismatch repair status and CDX-2 expression with inflammatory markers and pathological risk factors in stage ıı and ııı colon cancer: Multicenter real-life data. Journal of Gastrointestinal Cancer, 55(1), 227-236. http://dx.doi.org/10.1007/s12029-023-00953-0; http://dx.doi.org/10.1007/s12029-023-00953-0; https://hdl.handle.net/20.500.12511/12563; 55; 227; 236; 001014471300001; 2-s2.0-85162997296; Q3

  8. 8
  9. 9
    Academic Journal
  10. 10
    Academic Journal

    وصف الملف: application/pdf

    Relation: Japanese Journal of Clinical Oncology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Ölmez, Ö. F., Bilici, A., Er, Ö., Bişgin, A., Sevinç, A., Akman, T. . Alakavuklar, M. (2024). Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours—results from a Turkish multi-centre study. Japanese Journal of Clinical Oncology, 54(5), 562-568. http://dx.doi.org/10.1093/jjco/hyae002; http://dx.doi.org/10.1093/jjco/hyae002; https://hdl.handle.net/20.500.12511/12547; 54; 562; 568; Q4; 001148494000001; 2-s2.0-85192428470; Q2

  11. 11
    Academic Journal

    المؤلفون: Yıldiz, Anil1 (AUTHOR), Bilici, Ahmet1 (AUTHOR) ahmetknower@yahoo.com, Acikgoz, Ozgur1 (AUTHOR), Hamdard, Jamshid1 (AUTHOR), Basim, Pelin2 (AUTHOR), Cakir, Tansel3 (AUTHOR), Cakir, Asli4 (AUTHOR), Olmez, Omer Fatih1 (AUTHOR), Gezen, Cem2 (AUTHOR), Yildiz, Ozcan1 (AUTHOR)

    المصدر: Journal of Chemotherapy (Taylor & Francis Ltd). Feb2025, Vol. 37 Issue 1, p60-68. 9p.

  12. 12
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
  16. 16
    Academic Journal
  17. 17
    Academic Journal

    وصف الملف: application/pdf

    Relation: Turkish Journal of Medical Sciences; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Açıkgöz, Ö., Bilici, A., Tataroğlu Özyükseler, D., Göktaş Aydin, S., Selçukbiricik, F., Rzazade, R. . Başak Çağlar, H. (2023). Survival outcomes of patients with oligometastatic non-small cell lung cancer who were treated with radical therapy: A multicenter analysis. Turkish Journal of Medical Sciences, 53(4), 949-961. https://dx.doi.org/10.55730/1300-0144.5659; https://dx.doi.org/10.55730/1300-0144.5659; https://hdl.handle.net/20.500.12511/11416; 53; 949; 961; Q3; 001166710900012; 2-s2.0-85168797683; 1194046

  18. 18
    Academic Journal

    وصف الملف: application/pdf

    Relation: Acta Oncologica; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Bilici, A., Ölmez, Ö. F., Kaplan, M. A., Öksüzoğlu, B., Sezer, A., Karadurmuş, N. . Demirci, U. (2023). Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: A multicenter real-life HER2PATH study. Acta Oncologica, 62(4), 381-390. https://dx.doi.org/10.1080/0284186X.2023.2202330; https://dx.doi.org/10.1080/0284186X.2023.2202330; https://hdl.handle.net/20.500.12511/12365; 62; 381; 390; Q3; 000971681800001

  19. 19
    Academic Journal

    وصف الملف: application/pdf

    Relation: Biomolecules and Biomedicine; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Göktaş Aydın, S., Kavak, E. E., Topçu, A., Bayramgil, A., Akgül, F., Kahraman, S. . Şeker, M. (2023). Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study. Biomolecules and Biomedicine, 23(6), 1089-1095. https://dx.doi.org/10.17305/bb.2023.9253; https://dx.doi.org/10.17305/bb.2023.9253; https://hdl.handle.net/20.500.12511/11872; 23; 1089; 1095; 001101302800015; 2-s2.0-85176266462

  20. 20
    Academic Journal

    وصف الملف: application/pdf

    Relation: Medicina (Lithuania); Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Aydın, D., Kefeli, U., Özçelik, M., Erdem, G. U., Şendur, M. A., Yıldırım, M. E. . Gümüş, M. (2023). The prognostic utility of the metastatic lymph node ratio and the number of regional lymph nodes removed from patients with small bowel adenocarcinomas. Medicina (Lithuania), 59(8). https://dx.doi.org/10.3390/medicina59081472; https://dx.doi.org/10.3390/medicina59081472; https://hdl.handle.net/20.500.12511/11410; 59; Q3; 001056239200001; 2-s2.0-85168716369; Q2